Cone Beam Computed Tomography Following Thrombectomy
NCT: NCT03869567 · TERMINATED
Brief Summary
Cerebral haemorrhages following reperfusion treatments involve not only rupture of the blood-brain barrier, but also direct damage to vessels related to the equipment used and secondary toxicity to thrombolytics. The rupture of the blood-brain barrier which results from ischemia / reperfusion is responsible for stagnation of the contrast product on the exams performed after thrombectomy. It is difficult to distinguish hyperdensities related to the stagnation of contrast product and Hemorrhage on a conventional scanner. The reference imaging is the double energy scanner performed at the thrombectomy outlet. But no study directly compared the results of the flat panel with the cone beam CT performed in immediate post-thrombectomy. The investigators propose a direct comparison of the cone beam CT with the dual energy CT performed at the exit of thrombectomy.
Frequently Asked Questions
What is Cone Beam Computed Tomography Following Thrombectomy?
Cone Beam Computed Tomography Following Thrombectomy is a clinical trial registered under NCT03869567. Current status: TERMINATED.
What is the status of NCT03869567?
The current status of NCT03869567 (Cone Beam Computed Tomography Following Thrombectomy) is: TERMINATED.
When did Cone Beam Computed Tomography Following Thrombectomy start?
Cone Beam Computed Tomography Following Thrombectomy started on 2019-02-11.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.